JD Vance showed up to the second annual Maha summit in Washington this week not as a health policy enthusiast but as a 2028 presidential candidate doing coalition math. The vice-president traded memes with RFK Jr, mocked rival Marco Rubio's poker face, and positioned himself as the natural heir to both Maga and Maha — two movements he sees as fusing into a single electoral engine. The calculation is transparent: Kennedy's faction helped deliver 2024, and Vance wants that voter bloc locked in early. The problem is that the Maha movement is splitting along a familiar fault line. The summit's sponsor list — UnitedHealth, Walmart, Anthropic, and Grail (a cancer-treatment company with an active FDA application) — reads less like a grassroots health uprising and less like a pharma industry networking event only because pharma would have been subtler. Companies paying $300,000 received speaker slots and private dinners with Kennedy and CMS administrator Mehmet Oz, according to Bloomberg reporting. The event was organized by the Maha Center, one of several ventures run by Tony Lyons, who has paid Kennedy $4 million in the past year. Membership in Maha Holdings, whose sole board member is Kennedy's 29-year-old son Finn, costs $6,000 annually. The grassroots noticed. Anti-vaccine doctor Mary Talley Bowden asked publicly why activist voices were being excluded. Kelly Ryerson, the self-styled Glyphosate Girl, said the speaker lineup "could not be less Maha." Robert Malone, a conspiracy theorist and former vaccines advisory committee member, wrote on Substack that Maha had been "captured" by the corporate interests it originally opposed. These are not outside critics — they are the movement's own base calling foul. Meanwhile, an AP-KFF survey found 68% of rural Maha supporters said Trump's health policies have had a negative effect or no impact on local health outcomes. Fewer than one in four Americans (23%) view Kennedy favorably, per Annenberg. More Americans view both the president and vice-president unfavorably than favorably, according to Pew. The numbers suggest the Maha brand is depreciating even as Vance tries to acquire it. Vance used the summit to spotlight his anti-fraud task force, claiming $250 billion in Medicaid, Medicare, and ACA marketplace fraud discovered — though the administration has released almost no documentation of who was unenrolled or why. He blamed undocumented immigrants for receiving Medicare benefits, a claim for which no evidence exists. The rhetorical move is classic populist misdirection: frame cost reduction as fraud detection, blame a politically useful scapegoat, and avoid the structural question of why American healthcare costs dwarf those of every peer nation. Kennedy himself inadvertently highlighted that structural question by praising European health systems — which achieve better outcomes through universal coverage, the opposite of the Trump administration's deregulatory agenda. He then pivoted to promoting AI as a replacement for expert medical judgment, claiming it would be "malpractice" not to consult AI before making a diagnosis, a quote he attributed to Sam Altman. Current data shows AI chatbots are inaccurate about 25% of the time on medical queries. About 32% of Americans already consult AI for health information. The strategic picture is clear enough. Vance is betting that the Maha brand — even hollowed out and corporatized — retains enough populist energy to anchor a 2028 coalition. NYU's Art Caplan put it plainly: "If he can get half of what Trump got, even if there's a split, he's doing well." The question is whether a movement whose original supporters are openly revolting against its capture can still deliver votes, or whether Vance is acquiring a brand that will be worth less than he paid for it.
